Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial

Author(s):
Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Kranenbarg, E.M.K.; Kroep, J.R.; Putter, H.; Riet, Y. van; Nieuwenhuijzen, G.A.P.; Valk, B. de; Terwogt, J.M.M.; Algie, G.D.; Liefers, G.J.; Linn, S.; Velde, C.J.H. van de (0000-0003-0104-1800)
Published
2014
Publication type
Article / Letter to editor
Breast cancerBreast conserving surgeryEndocrine therapyExemestanePostmenopausalPre-operativeNeoadjuvant
Date issued
2014-09-30
Language
English
Is part of
European Journal of Cancer (2014), Vol. 50, no. 13, p. 2190-2200
hdl
1887/108122
doi
10.1016/j.ejca.2014.05.010